Showing results (101-110 of 151) with videos related to
Sort By:
Pageof 16
Circulation|September 30, 1998
Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverseG S Huggins, R C Pasternak, N M Alpert, et al.The American Journal of Cardiology|November 3, 2004
Understanding physician and consumer attitudes concerning cholesterol management: results from the National Lipid Association surveysRichard C Pasternak, James M McKenney, W Virgil Brown, et al.The American Journal of Cardiology|May 1, 1987
Need for better severity indexes of acute myocardial infarction under diagnosis-related groupsG I Barbash, C Safran, B J Ransil, et al.The American Journal of Cardiology|September 28, 1995
The influence of pretreatment low density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trials. Harvard Atherosclerosis Reversibility Project Research GroupF M Sacks, C M Gibson, B Rosner, et al.Journal of the American College of Cardiology|November 15, 1993
Cost-effectiveness of a smoking cessation program after myocardial infarctionH M Krumholz, B J Cohen, J Tsevat, et al.The Journal of Thoracic and Cardiovascular Surgery|October 1, 1979
Variant angina. Clinical spectrum and results of medical and surgical therapyR C Pasternak, A M Hutter, R W DeSanctis, et al.Journal of Autoimmunity|December 31, 2018
Role of NOD2 in antiphospholipid antibody-induced and bacterial MDP amplification of trophoblast inflammationMelissa J Mulla, Monica C Pasternak, Jane E Salmon, et al.The Journal of Biological Chemistry|August 11, 1995
Fibroblast contractility without an increase in basal myosin light chain phosphorylation in wild type cells and cells expressing the catalytic domain of myosin light chain kinaseK Obara, G Nikcevic, L Pestic, et al.The American Journal of Cardiology|May 15, 1992
Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trialsC M Gibson, T Sandor, P H Stone, et al.The American Journal of Physiology|November 11, 1996
Expression of the catalytic domain of myosin light chain kinase increases paracellular permeabilityG Hecht, L Pestic, G Nikcevic, et al.Pageof 16